Αρχειοθήκη ιστολογίου

Τετάρτη 23 Αυγούστου 2017

Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics

Although major improvements have been made in surgical management, chemotherapeutic, and radiotherapeutic of prostate cancer, many prostate cancers remain refractory to treatment with standard agents. Therefor...

from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2isxppJ

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου